- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/34 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 207/34
Total number of patents in this class: 594
10-year publication summary
39
|
29
|
26
|
30
|
37
|
46
|
29
|
34
|
21
|
13
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2703 |
17 |
Daiichi Sankyo Company, Limited | 1849 |
17 |
Sunshine Lake Pharma Co., Ltd. | 585 |
14 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 687 |
12 |
Viatris Specialty LLC | 159 |
11 |
Syngenta Participations AG | 1927 |
9 |
Syngenta Crop Protection AG | 6013 |
8 |
Theravance Biopharma R&D IP, LLC | 462 |
8 |
Bayer Cropscience SA | 42 |
7 |
Activesite Pharmaceuticals, Inc. | 18 |
7 |
AstraZeneca AB | 2928 |
6 |
FUJIFILM Corporation | 29188 |
6 |
Astellas Pharma Inc. | 1083 |
6 |
Emory University | 1619 |
6 |
Global Blood Therapeutics, Inc. | 183 |
6 |
Kissei Pharmaceutical Co., Ltd. | 184 |
6 |
New York Blood Center, Inc. | 159 |
6 |
VenatoRx Pharmaceuticals, Inc. | 84 |
6 |
Janssen Pharmaceutica N.V. | 3431 |
5 |
Bayer Cropscience AG | 2074 |
5 |
Other owners | 426 |